2-amino-3,4-dimethylimidazo(4,5-f)quinoline and Cocarcinogenesis

2-amino-3,4-dimethylimidazo(4,5-f)quinoline has been researched along with Cocarcinogenesis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hiroyasu, BT; Kim, DJ; Park, CB; Takasuka, N; Tsuda, H; Uehara, N	1

Other Studies

1 other study(ies) available for 2-amino-3,4-dimethylimidazo(4,5-f)quinoline and Cocarcinogenesis

Article	Year
Heterozygous p53-deficient mice are not susceptible to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) carcinogenicity. Cancer letters, 1999, May-24, Volume: 139, Issue:2 Topics: Alleles; Animals; Body Weight; Carcinogens; Cocarcinogenesis; Dose-Response Relationship, Drug; Female; Genes, p53; Hematologic Neoplasms; Heterozygote; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Mice; Mice, Knockout; Mutagens; Neoplasms, Experimental; Quinolines; Tumor Suppressor Protein p53	1999

Article

Year

Heterozygous p53-deficient mice are not susceptible to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) carcinogenicity.

Cancer letters, 1999, May-24, Volume: 139, Issue:2

Topics: Alleles; Animals; Body Weight; Carcinogens; Cocarcinogenesis; Dose-Response Relationship, Drug; Female; Genes, p53; Hematologic Neoplasms; Heterozygote; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Mice; Mice, Knockout; Mutagens; Neoplasms, Experimental; Quinolines; Tumor Suppressor Protein p53

1999